We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$127B
1-Year Est. Return
46.06%
This Fund
S&P 500
This Quarter
Est. Return
+26.15%
1 Year Est. Return
+46.06%
3 Year Est. Return
+142.12%
5 Year Est. Return
+190.33%
10 Year Est. Return
+787.47%
AUM
$127B
AUM Growth
+$26.3B
(+26%)
Cap. Flow
+$9.28B
Cap. Flow
% of AUM
7.32%
Top 10 Holdings %
Top 10 Hldgs %
37.66%
Holding
3,898
New
771
Increased
1,083
Reduced
1,182
Closed
795
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$9.86B |
| 2 |
Costco
COST
|
+$907M |
| 3 |
AbbVie
ABBV
|
+$643M |
| 4 |
JPMorgan Chase
JPM
|
+$609M |
| 5 |
Bank of America
BAC
|
+$567M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.03B |
| 2 |
Mercado Libre
MELI
|
+$528M |
| 3 |
Broadcom
AVGO
|
+$514M |
| 4 |
SNDK
Sandisk
SNDK
|
+$507M |
| 5 |
Marvell Technology
MRVL
|
+$499M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 34.91% |
| 2 | Technology | 20.64% |
| 3 | Consumer Discretionary | 9.1% |
| 4 | Healthcare | 8.21% |
| 5 | Financials | 7.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1476
CF Bankshares
CFBK
$232M
| $3.89M | ﹤0.01% |
118,575
+86,054
| +265% | +$2.5M |
|
|
INGM
1477
Ingram Micro Holding
INGM
$6.55B
| $3.86M | ﹤0.01% |
+140,725
| New | +$3.95M |
|
|
CBIO
1478
Crescent Biopharma
CBIO
$760M
| $3.86M | ﹤0.01% |
214,300
+13,520
| +7% | +$264K |
|
1479
Galectin Therapeutics
GALT
$418M
| $3.86M | ﹤0.01% |
831,010
-388,902
| -32% | -$1.01M |
|
|
GCTS
1480
GCT Semiconductor Holding
GCTS
$166M
| $3.85M | ﹤0.01% |
+1,296,433
| New | +$2.75M |
|
1481
Skywest
SKYW
$3.69B
| $3.85M | ﹤0.01% |
+38,719
| New | +$3.45M |
|
1482
Ondas Inc
ONDS
$4.35B
| $3.85M | ﹤0.01% |
466,734
-4,406,976
| -90% | -$43.5M |
|
1483
PUT
Eli Lilly
LLY
$1T
| $3.84M | ﹤0.01% |
3,200
-79,400
| -96% | -$81.1M |
|
1484
InMode
INMD
$852M
| $3.82M | ﹤0.01% |
261,587
+36,872
| +16% | +$514K |
|
|
PURR
1485
Hyperliquid Strategies Inc
PURR
$2.36B
| $3.8M | ﹤0.01% |
483,364
-56,281
| -10% | -$417K |
|
1486
Dollar Tree
DLTR
$23.3B
| $3.8M | ﹤0.01% |
31,425
-42,936
| -58% | -$4.46M |
|
|
ARTY
1487
iShares Future AI & Tech ETF
ARTY
$4.08B
| $3.8M | ﹤0.01% |
+49,858
| New | +$3.3M |
|
1488
United Microelectronic
UMC
$54.7B
| $3.8M | ﹤0.01% |
139,510
-65,904
| -32% | -$1.13M |
|
1489
StoneCo
STNE
$2.31B
| $3.79M | ﹤0.01% |
+349,727
| New | +$4.14M |
|
1490
RCI Hospitality Holdings
RICK
$222M
| $3.79M | ﹤0.01% |
138,624
+23,001
| +20% | +$583K |
|
1491
iShares MSCI EAFE ETF
EFA
$79.7B
| $3.77M | ﹤0.01% |
36,265
+23,536
| +185% | +$2.42M |
|
1492
Grupo Cibest SA
CIB
$23.3B
| $3.76M | ﹤0.01% |
+47,373
| New | +$3.42M |
|
1493
Red Violet
RDVT
$1.2B
| $3.76M | ﹤0.01% |
58,962
-75,627
| -56% | -$3.58M |
|
|
OSG
1494
Octave Specialty Group
OSG
$223M
| $3.76M | ﹤0.01% |
601,796
-463,539
| -44% | -$2.41M |
|
1495
Cimpress
CMPR
$2.07B
| $3.73M | ﹤0.01% |
36,654
+26,098
| +247% | +$2.32M |
|
1496
J&J Snack Foods
JJSF
$1.56B
| $3.73M | ﹤0.01% |
50,721
-20,555
| -29% | -$1.6M |
|
1497
Verra Mobility
VRRM
$594M
| $3.72M | ﹤0.01% |
875,775
+865,375
| +8,321% | +$9.13M |
|
1498
LivaNova
LIVN
$4.45B
| $3.7M | ﹤0.01% |
45,036
+19,013
| +73% | +$1.34M |
|
1499
Certara
CERT
$1.18B
| $3.7M | ﹤0.01% |
564,739
-166,143
| -23% | -$936K |
|
1500
PBF Energy
PBF
$9.1B
| $3.7M | ﹤0.01% |
81,252
-1,149,650
| -93% | -$47.8M |
|
Similar funds
Marshall Wace's Q2 2026 Portfolio in Review
As of Q2 2026, Marshall Wace held 3,898 positions worth $127B, up 26% from $100B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Marshall Wace deployed $9.28B of net new capital in Q2 2026, opening 771 new positions and adding to 1,083 existing holdings. Its largest new stake was LPL Financial: 975,627 shares worth $275M.
By sector, the portfolio is most concentrated in Miscellaneous at 35% of assets, up from 30% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was NVIDIA, an estimated $1.03B trimmed.
- Marshall Wace's largest Q2 2026 buy was LPL Financial: 975,627 shares worth $275M.
- Marshall Wace added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $9.86B increase.
- Marshall Wace's biggest Q2 2026 reduction was NVIDIA, cutting an estimated $1.03B.
- Marshall Wace fully exited Merck in Q2 2026, selling an estimated $325M.
- Marshall Wace's ten largest holdings make up 38% of its $127B portfolio in Q2 2026.
- Marshall Wace opened 771 new positions and closed 795 in Q2 2026.
- Marshall Wace's portfolio value rose 26% quarter-over-quarter to $127B.
Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.